Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A global federated real-world data and analytics platform for research
Matvey B. Palchuk, Jack London, David Pérez-Rey, et al.
JAMIA Open (2023) Vol. 6, Iss. 2
Open Access | Times Cited: 200

Showing 1-25 of 200 citing articles:

Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes
Lindsey Wang, Rong Xu, David C. Kaelber, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2421305-e2421305
Open Access | Times Cited: 71
Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes
Min‐Hsiang Chuang, Jui‐Yi Chen, Hsien‐Yi Wang, et al.
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2427258-e2427258
Open Access | Times Cited: 24
Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database
Aikaterini Eleftheriadou, David R. Riley, Sizheng Steven Zhao, et al.
Diabetologia (2024) Vol. 67, Iss. 7, pp. 1271-1282
Open Access | Times Cited: 21
Glucagon‐Like Peptide‐1 Receptor Agonists and Liver Outcomes in Patients With MASLD and Type 2 Diabetes
Chia‐Chih Kuo, Min‐Hsiang Chuang, Chun‐Hsien Li, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 4
Robotic-assistance is associated with better joint outcomes compared to conventional techniques in surgically routine total hip arthroplasty: a propensity-matched large database study of 3948 patients
Aakash K. Shah, Monish S. Lavu, Robert J. Burkhart, et al.
Archives of Orthopaedic and Trauma Surgery (2025) Vol. 145, Iss. 1
Open Access | Times Cited: 2
Artificial intelligence methods applied to longitudinal data from electronic health records for prediction of cancer: a scoping review
Victoria Moglia, Owen Johnson, G. Elliott Cook, et al.
BMC Medical Research Methodology (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 2
A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX
Ralf J. Ludwig, Matthew Anson, Henner Zirpel, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 2
Cannabis Use and Head and Neck Cancer
Tyler J. Gallagher, Ryan S. Chung, Matthew E. Lin, et al.
JAMA Otolaryngology–Head & Neck Surgery (2024)
Closed Access | Times Cited: 14
Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure
Katherine L. Modzelewski, Alexandra Pipilas, Nicholas A. Bosch
JAMA Network Open (2024) Vol. 7, Iss. 5, pp. e249305-e249305
Open Access | Times Cited: 13
Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative Disorders: A Large-Scale Propensity-Matched cohort study
Nabeela Siddeeque, Mohammad H. Hussein, Ahmed Abd‐Elmaksoud, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113537-113537
Open Access | Times Cited: 11
Morbidity and mortality risks associated with valproate withdrawal in young men and women with epilepsy
Gashirai K Mbizvo, Tommaso Bucci, Gregory Y.H. Lip, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3426-3441
Closed Access | Times Cited: 10
Effect of glucagon-like peptide-1 receptor agonists on vascular risk factors among adults with type 2 diabetes and established atherosclerotic cardiovascular disease
Aaron A. King, Xi Tan, Neil Dhopeshwarkar, et al.
American Journal of Preventive Cardiology (2025) Vol. 21, pp. 100922-100922
Open Access | Times Cited: 1
The Impact of Contemporary Glucagon-like Peptide-1 Receptor Agonists on the Onset, Severity, and Conversion to Arthroplasty in Hip and Knee Osteoarthritis
Joshua R. Porto, Monish S. Lavu, Christian J. Hecht, et al.
Orthopaedic Journal of Sports Medicine (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Cardiovascular and thromboembolic outcomes with immune checkpoint inhibitors in gastroesophageal cancer: a propensity score-matched cohort study
Furkan Bahar, Betul Ibis, Selçuk Çolak, et al.
Gastric Cancer (2025)
Closed Access | Times Cited: 1
Mortality and Medical Utilization in Rheumatoid Arthritis Associated Interstitial Lung Disease: A Real-World, Large-Scale Retrospective Study Comparing Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors.
Po‐Cheng Shih, Qinghua Zou, Chih-Cheng Lai, et al.
Seminars in Arthritis and Rheumatism (2025) Vol. 71, pp. 152636-152636
Closed Access | Times Cited: 1
Demographic Disparities in Diagnosis and Treatment of Anxiety and Depressive Disorders in Head and Neck Cancer Survivors
Tyler J. Gallagher, Ryan S. Chung, Nyree Khachikyan, et al.
Head & Neck (2025)
Open Access | Times Cited: 1
Efficacy of Tirzepatide Dual GIP/GLP‐1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real‐World Propensity Score‐Matched Study
Ahmed Y. Azzam, Muhammed Amir Essibayi, Nathan Farkas, et al.
Endocrinology Diabetes & Metabolism (2025) Vol. 8, Iss. 2
Open Access | Times Cited: 1
Sarcoidosis Treatment Patterns in the United States
Marios Rossides, Elizabeth V. Arkema
CHEST Journal (2025) Vol. 167, Iss. 4, pp. 928-930
Closed Access | Times Cited: 1
Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort study
Henning Olbrich, Khalaf Kridin, Gema Hernández, et al.
EBioMedicine (2024) Vol. 103, pp. 105123-105123
Open Access | Times Cited: 8
Five-year Incidence of Progression to Osteoarthritis and Total Joint Arthroplasty in Patients Prescribed Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists
Monish S. Lavu, Joshua R. Porto, Christian J. Hecht, et al.
The Journal of Arthroplasty (2024)
Closed Access | Times Cited: 8
Association of antiseizure medications and adverse cardiovascular events: A global health federated network analysis
Joséphine Mayer, Gashirai K Mbizvo, Tommaso Bucci, et al.
Epilepsia (2024) Vol. 65, Iss. 5, pp. 1264-1274
Open Access | Times Cited: 7
Cataract Development Among Pediatric Patients With Uveitis
Alan Y. Hsu, Hou‐Ting Kuo, Chun-Ju Lin, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2419366-e2419366
Open Access | Times Cited: 7
Risk of death, major adverse cardiac events and relapse in patients with bullous pemphigoid treated with systemic or topical corticosteroids
Khalaf Kridin, Katja Bieber, Artem Vorobyev, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 539-547
Closed Access | Times Cited: 6
Exploring the mortality and cardiovascular outcomes with SGLT-2 inhibitors in patients with T2DM at dialysis commencement: a health global federated network analysis
Chung-An Wang, Li‐Chun Lin, Jui‐Yi Chen, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Association between Glucagon-Like Peptide-1 Receptor Agonists and Aspiration Pneumonia during Endoscopic Procedures
Chun-Yu Peng, Yu-Cheng Chang, Changlin Gong, et al.
Anesthesiology (2024)
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top